For Quick Alerts
For Daily Alerts

Dr Reddy's Lab dips over 13 per cent on USFDA warning

By Religare

Shares of Dr Reddy's Lab fell over 13 per cent on Bombay Stock Exchange (BSE) after the company received a warning letter issued by the USFDA dated November 5 pertaining to its API manufacturing facilities situated at Srikakulam in Andhra Pradesh and Miryalaguda in Tamil Nadu and also at its Oncology formulation manufacturing facility located in Duvvada in Andhra Pradesh.

Reacting to the news, shares of company dropped 13.34 per cent to Rs 3685.45 apiece on the BSE.


Shares of the company dipped 13.45 per cent to Rs 3677.80 a piece on National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 26,326.18, up 21.98 points, or 0.08 per cent, at 11:10 hours.

Read more about: dr reddys laboratories
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more